Robocath announced today that it completed the first robotic coronary angioplasties with its R-One robotic catheter guidance system in Germany.
Professor Michael Haude, director of Medical Clinic I at Rheinland Klinikum Neuss Lukaskrankenhaus, and his team, performed the percutaneous coronary interventions with the R-One system.
Rouen, France-based Robocath CEO Lucien Goffart believes the procedures in Germany are an important strategic step for the company, given interest from around the industry, according to a news release.
“I’m proud to be the first user of this brand new European robotic solution for PCI in Germany,” Haude said in the news release. “These robotic interventions pave the way for a new era in interventional cardiology. The benefits brought by R-One are huge for practitioners and will drastically improve our working conditions, which will consequently benefit patient care. My team and I look forward to integrating this robotic-assisted platform for PCI into our day-to-day clinical practice.”
“Professor Haude has over 30 years of experience in interventional cardiology and we rely on capitalizing on this kind of experience to develop clinical evidence and demonstrate all the benefits of our solution,” added Robocath chairman & founder Philippe Bencteux.
R-One is designed to enable and enhance interventional procedures, such as coronary angioplasty, “offering a better working environment for physicians and the entire medical team,” according to Robocath.
The R-One device won CE Mark approval in February and raised $5.5 million in September, which it had earmarked for the R-One platform. In May 2017, Robocath picked up $5.2 million in one funding round, before raising another $2 million just over six months later.
Also in September, the company announced that it completed its first two coronary angioplasties performed with the R-One. Both procedures were performed in France. Last month, the R-One completed a coronary angioplasty for the first time in Africa.